|
1
|
Fadare O, Chacho MS and Parkash V:
Psammoma bodies in cervicovaginal smears: Significance and
practical implications for diagnostic cytopathology. Adv Anat
Pathol. 11:250–261. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Das DK: Psammoma body: A product of
dystrophic calcification or of a biologically active process that
aims at limiting the growth and spread of tumor? Diagn Cytopathol.
37:534–541. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han J, Daniel JC and Pappas GD: Expression
of type VI collagen in psammoma bodies: Immunofluorescence studies
on two fresh human meningiomas. Acta Cytol. 40:177–181. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johannessen JV and Sobrinho-Simoes M: The
origin and significance of thyroid psammoma bodies. Lab Invest.
43:287–296. 1980.PubMed/NCBI
|
|
5
|
Pyo JS, Kang G, Kim DH, Park C, Kim JH and
Sohn JH: The prognostic relevance of psammoma bodies and
ultrasonographic intratumoral calcifications in papillary thyroid
carcinoma. World J Surg. 37:2330–2335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carneiro SS, Scheithauer BW, Nascimento
AG, Hirose T and Davis DH: Solitary fibrous tumor of the meninges:
A lesion distinct from fibrous meningioma. A clinicopathologic and
immunohistochemical study. Am J Clin Pathol. 106:217–224. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cai YF, Wang QX, Ni CJ, Guo GL, Li Q, Wang
OC, Wu L, Du HY, You J and Zhang XH: The clinical relevance of
psammoma body and hashimoto thyroiditis in papillary thyroid
carcinoma: A large case-control study. Medicine (Baltimore).
94:e18812015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Armah HB and Parwani AV: Xp11.2
translocation renal cell carcinoma. Arch Pathol Lab Med.
134:124–129. 2010.PubMed/NCBI
|
|
9
|
Delahunt B, Eble JN, McCredie MR,
Bethwaite PB, Stewart JH and Bilous AM: Morphologic typing of
papillary renal cell carcinoma: Comparison of growth kinetics and
patient survival in 66 cases. Hum Pathol. 32:590–595. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Argani P, Olgac S, Tickoo SK, Goldfischer
M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, et al:
Xp11 translocation renal cell carcinoma in adults: Expanded
clinical, pathologic, and genetic spectrum. Am J Surg Pathol.
31:1149–1160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Yang Y, Gan W, Xu L, Ye Q and Guo
H: Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay
are useful in diagnosing Xp11.2 translocation renal cell carcinoma
and ASPL-TFE3 renal cell carcinoma: A STARD-compliant article.
Medicine (Baltimore). 94:e8732015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu N, Wang Z, Gan W, Xiong L, Miao B,
Chen X, Guo H and Li D: Renal cell carcinoma associated with Xp11.2
translocation/TFE3 gene fusions: Clinical features, treatments and
prognosis. PLoS One. 11:e01668972016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Das DK, Mallik MK, Haji BE, Ahmed MS,
Al-Shama'a M, Al-Ayadhy B, George SS, Sathar SA and Junaid TA:
Psammoma body and its precursors in papillary thyroid carcinoma: A
study by fine-needle aspiration cytology. Diagn Cytopathol.
31:380–386. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-Part A: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tabuchi K, Kawakami Y and Nishimoto A:
Immunohistochemical demonstration of IgG in meningioma. Acta
Neurochir (Wien). 55:201–211. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kiyozuka Y, Nakagawa H, Senzaki H, Uemura
Y, Adachi S, Teramoto Y, Matsuyama T, Bessho K and Tsubura A: Bone
morphogenetic protein-2 and type IV collagen expression in psammoma
body forming ovarian cancer. Anticancer Res. 21:1723–1730.
2001.PubMed/NCBI
|
|
18
|
Cohen RJ, Weinstein S, Robertson T,
Sellner LN, Dawkins HJ and McNeal JE: Variant chromophobe renal
cell carcinoma. Arch Pathol Lab Med. 124:904–906. 2000.PubMed/NCBI
|
|
19
|
Amin MB, Crotty TB, Tickoo SK and Farrow
GM: Renal oncocytoma: A reappraisal of morphologic features with
clinicopathologic findings in 80 cases. Am J Surg Pathol. 21:1–12.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu Y, Gu C, Wang H, Chang K, Yang X, Zhou
X, Dai B, Zhu Y, Shi G, Zhang H and Ye D: Diagnosis of adults
Xp11.2 translocation renal cell carcinoma by immunohistochemistry
and FISH assays: Clinicopathological data from ethnic Chinese
population. Sci Rep. 6:216772016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rao Q, Chen JY, Wang JD, Ma HH, Zhou HB,
Lu ZF and Zhou XJ: Renal cell carcinoma in children and young
adults: Clinicopathological, immunohistochemical, and VHL gene
analysis of 46 cases with follow-up. Int J Surg Pathol. 19:170–179.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zou H, Kang X, Pang LJ, Hu W, Zhao J, Qi
Y, Hu J, Liu C, Li H, Liang W, et al: Xp11 translocation renal cell
carcinoma in adults: A clinicopathological and comparative genomic
hybridization study. Int J Clin Exp Pathol. 7:236–245.
2014.PubMed/NCBI
|
|
23
|
He J, Huan Y, Qiao Q, Zhang J and Zhang
JS: Renal carcinomas associated with Xp11.2 translocations: Are CT
findings suggestive of the diagnosis? Clin Radiol. 69:45–51. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Komai Y, Fujiwara M, Fujii Y, Mukai H,
Yonese J, Kawakami S, Yamamoto S, Migita T, Ishikawa Y, Kurata M,
et al: Adult Xp11 translocation renal cell carcinoma diagnosed by
cytogenetics and immunohistochemistry. Clin Cancer Res.
15:1170–1176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Camparo P, Vasiliu V, Molinie V, Couturier
J, Dykema KJ, Petillo D, Furge KA, Comperat EM, Lae M, Bouvier R,
et al: Renal translocation carcinomas: Clinicopathologic,
immunohistochemical, and gene expression profiling analysis of 31
cases with a review of the literature. Am J Surg Pathol.
32:656–670. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klatte T, Streubel B, Wrba F, Remzi M,
Krammer B, de Martino M, Waldert M, Marberger M, Susani M and
Haitel A: Renal cell carcinoma associated with transcription factor
E3 expression and Xp11.2 translocation: Incidence, characteristics,
and prognosis. Am J Clin Pathol. 137:761–768. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haji BE, Ahmed MS, Prasad A, Omar MS and
Das DK: Papillary thyroid carcinoma with an adenoid cystic pattern:
Report of a case with fine-needle aspiration cytology and
immunocytochemistry. Diagn Cytopathol. 30:418–421. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ellis CL, Eble JN, Subhawong AP,
Martignoni G, Zhong M, Ladanyi M, Epstein JI, Netto GJ and Argani
P: Clinical heterogeneity of Xp11 translocation renal cell
carcinoma: Impact of fusion subtype, age, and stage. Mod Pathol.
27:875–886. 2014. View Article : Google Scholar : PubMed/NCBI
|
